Innova Captab Share Price

This is to inform you that the Board of Directors of the Company at its meeting held on Friday, 13th November, 2026, has approved the unaudited (standalone and consolidated) financial results of the Company for the quarter and half year ended 30th September, 2026. In this regard and pursuant to the provisions of regulation 47 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we are enclosing herewith the extract of the newspaper advertisement dated 14th November, 2026, published in the following newspapers: 1. The Financial Express (English newspaper) 2. The Mumbai Lakshdeep (Marathi newspaper)

• BSE India
• 14 hours 32 minutes ago

This is in continuation of our intimation dated 05th November, 2026 wherein we had informed regarding an earnings call scheduled with analysts/investors on Monday, 16th November, 2026 at 11:00 hours (IST) to discuss the unaudited financial results for the quarter and half year ended 30th September, 2026.

• BSE India
• 1 day 9 hours ago

<h3><span style="font-size:16px;"><strong>Pharmaceuticals company Innova Captab announced Q2FY27 results</strong></span></h3> <p><strong>Consolidated Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIDBAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="YBfvme_1n"> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="YBfvme_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="YBfvme_1s">Revenue from Operations:<!--TgQPHd|||[]--></strong> Consolidated revenue from operations stood at Rs 4,962.99 million<!--TgQPHd|||[]--> in Q2FY27, reflecting a 5.40% QoQ<!--TgQPHd|||[]--> increase from Rs 4,708.52 million in Q1FY27 and a 30.47% YoY<!--TgQPHd|||[]--> growth from Rs 3,803.81 million in Q2FY26. For H1FY27, consolidated revenue from operations reached Rs 9,671.51 million<!--TgQPHd|||[]-->, up 32.14% YoY<!--TgQPHd|||[]--> compared to Rs 7,319.23 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="YBfvme_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="YBfvme_26">Total Income:<!--TgQPHd|||[]--></strong> Consolidated total income was Rs 4,987.63 million<!--TgQPHd|||[]--> in Q2FY27, rising 5.48% QoQ<!--TgQPHd|||[]--> from Rs 4,728.59 million in Q1FY27 and 29.69% YoY<!--TgQPHd|||[]--> from Rs 3,845.74 million in Q2FY26. In H1FY27, consolidated total income grew 31.19% YoY<!--TgQPHd|||[]--> to Rs 9,716.22 million<!--TgQPHd|||[]--> against Rs 7,405.99 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="YBfvme_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="YBfvme_2k">Profit Before Tax (PBT):<!--TgQPHd|||[]--></strong> Consolidated PBT stood at Rs 562.98 million<!--TgQPHd|||[]--> in Q2FY27, marking a 4.56% QoQ<!--TgQPHd|||[]--> decline from Rs 589.85 million in Q1FY27 but a 43.49% YoY<!--TgQPHd|||[]--> jump from Rs 392.35 million in Q2FY26. For H1FY27, consolidated PBT increased 40.74% YoY<!--TgQPHd|||[]--> to Rs 1,152.83 million<!--TgQPHd|||[]--> compared to Rs 819.12 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="YBfvme_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="YBfvme_2y">Profit After Tax (PAT):<!--TgQPHd|||[]--></strong> Consolidated PAT (attributable to owners of the parent company) was Rs 424.22 million<!--TgQPHd|||[]--> in Q2FY27, down 3.86% QoQ<!--TgQPHd|||[]--> from Rs 441.26 million in Q1FY27 and up 42.98% YoY<!--TgQPHd|||[]--> from Rs 296.70 million in Q2FY26. In H1FY27, consolidated PAT rose 42.62% YoY<!--TgQPHd|||[]--> to Rs 865.48 million<!--TgQPHd|||[]--> from Rs 606.85 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="YBfvme_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="YBfvme_3c">Earnings Per Share (EPS):<!--TgQPHd|||[]--></strong> Consolidated basic and diluted EPS (not annualised) stood at Rs 7.41<!--TgQPHd|||[]--> in Q2FY27, decreasing 3.89% QoQ<!--TgQPHd|||[]--> from Rs 7.71 in Q1FY27 and increasing 43.05% YoY<!--TgQPHd|||[]--> from Rs 5.18 in Q2FY26. For H1FY27, consolidated EPS rose 42.64% YoY<!--TgQPHd|||[]--> to Rs 15.12<!--TgQPHd|||[]--> compared to Rs 10.60 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><!--TgQPHd|||[]--></p> <p><strong>Standalone Financial Highlights:</strong><span style="display: none;"> </span><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIDBAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="YBfvme_1n"> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="YBfvme_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="YBfvme_44">Revenue from Operations:<!--TgQPHd|||[]--></strong> Standalone revenue from operations reached Rs 4,047.75 million<!--TgQPHd|||[]--> in Q2FY27, up 1.07% QoQ<!--TgQPHd|||[]--> from Rs 4,004.76 million in Q1FY27 and 39.66% YoY<!--TgQPHd|||[]--> from Rs 2,898.31 million in Q2FY26. For H1FY27, standalone revenue from operations increased 39.60% YoY<!--TgQPHd|||[]--> to Rs 8,052.51 million<!--TgQPHd|||[]--> from Rs 5,768.10 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="YBfvme_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="YBfvme_4d">Total Income:<!--TgQPHd|||[]--></strong> Standalone total income stood at Rs 4,076.75 million<!--TgQPHd|||[]--> in Q2FY27, growing 1.12% QoQ<!--TgQPHd|||[]--> from Rs 4,031.78 million in Q1FY27 and 38.45% YoY<!--TgQPHd|||[]--> from Rs 2,944.62 million in Q2FY26. In H1FY27, standalone total income rose 38.43% YoY<!--TgQPHd|||[]--> to Rs 8,108.53 million<!--TgQPHd|||[]--> against Rs 5,857.56 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="YBfvme_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="YBfvme_4m">Profit Before Tax (PBT):<!--TgQPHd|||[]--></strong> Standalone PBT was Rs 420.22 million<!--TgQPHd|||[]--> in Q2FY27, dipping 2.35% QoQ<!--TgQPHd|||[]--> from Rs 430.34 million in Q1FY27 while surging 118.08% YoY<!--TgQPHd|||[]--> from Rs 192.69 million in Q2FY26. For H1FY27, standalone PBT grew 82.68% YoY<!--TgQPHd|||[]--> to Rs 850.56 million<!--TgQPHd|||[]--> compared to Rs 465.61 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="YBfvme_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="YBfvme_4v">Profit After Tax (PAT):<!--TgQPHd|||[]--></strong> Standalone PAT stood at Rs 319.69 million<!--TgQPHd|||[]--> in Q2FY27, remaining nearly flat at -0.28% QoQ<!--TgQPHd|||[]--> from Rs 320.60 million in Q1FY27 and surging 123.03% YoY<!--TgQPHd|||[]--> from Rs 143.34 million in Q2FY26. In H1FY27, standalone PAT increased 84.90% YoY<!--TgQPHd|||[]--> to Rs 640.29 million<!--TgQPHd|||[]--> against Rs 346.29 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="YBfvme_1q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="YBfvme_54">Earnings Per Share (EPS):<!--TgQPHd|||[]--></strong> Standalone basic and diluted EPS (not annualised) was Rs 5.59<!--TgQPHd|||[]--> in Q2FY27, changing -0.18% QoQ<!--TgQPHd|||[]--> from Rs 5.60 in Q1FY27 and rising 123.60% YoY<!--TgQPHd|||[]--> from Rs 2.50 in Q2FY26. For H1FY27, standalone EPS grew 84.96% YoY<!--TgQPHd|||[]--> to Rs 11.19<!--TgQPHd|||[]--> from Rs 6.05 in H1FY26.</li> </ul> <p><strong>Vinay Lohariwala, Managing Director, Innova Captab, said:</strong> “Innova Captab Limited delivered a strong performance in Q2FY27, with revenue growing 30.5% YoY to Rs 496.3 crore, EBITDA increasing 29.2% to Rs 72.4 crore and PAT growing 43.0% to Rs 42.4 crore.</p> <p>The performance underscores the continued strength of our diversified business model and disciplined execution across our business operations.</p> <p>The company continued to witness healthy business momentum across its CDMO and Branded Generics businesses, supported by a diversified product portfolio and deeper customer engagement. Our focus on operational excellence, manufacturing efficiency and quality continues to strengthen our competitive positioning and enables us to meet the evolving requirements of domestic and international markets. We are unequivocally focused on continued Jammu ramp-up alongside further strengthening of our manufacturing capabilities.</p> <p>Going forward, the company remains committed to strengthening its CDMO positioning, expanding its branded generics presence and ramping up manufacturing capacities. We remain confident of sustaining long-term growth and value for stakeholders through our strategic roadmap focusing on timely and disciplined capital allocation decisions.”</p> <p><a class="lb" href="/get-document/post/pdf/5949422/" target="_blank">Result PDF</a></p>

• Trendlyne
• 1 day 11 hours ago